Healthcare-Acquired Infection: Devices, Pharmaceuticals, and Environmental Products: 2021-2026

The report focuses on select drugs (antimicrobials), environment treatment (disinfectants, sterilization systems etc.) and provisions in medical devices (e.g., catheters, patient ventilation devices, sterile IV filters) that prevent the occurrence of nosocomial infections.

Within each type of treatment, regional analyses will focus on the Americas (i.e., Canada, the U.S., Mexico, Central America and South America), EMRA (i.e., Europe, the Middle East, Russia and Africa) and Asia-Pacific (i.e., Japan, China, India, other Western Pacific countries such as Australia and New Zealand, and other Southeast Asian countries).

The Report Includes:

72 tables
An updated review of the global healthcare-acquired infection (HCAI)-control market
Analyses of the global market trends, with data from 2020, estimates for 2021 and projections of compound annual growth rates (CAGRs) through 2026
Highlights of select antimicrobials drugs and environment sterilization/disinfection products currently used or under development for treatment of healthcare-associated infections
Market outlook and forecast trends of pharmaceutical treatment (antimicrobials and vaccines), environment treatment (disinfectants, sterilization systems etc.) and provisions in medical devices (catheters, patient ventilation devices, sterile intravenous [IV] filters) that prevent the occurrence of nosocomial infections
Estimation of the market size and revenue forecasts for HCAI-control market, and corresponding market share analysis by key market segments - technology type, application, and geography
Discussion of the key market dynamics, industry structure, regulatory approval, market deterrents, unmet needs and other factors driving opportunities in microbiology research
A look at the pipeline products for antimicrobial resistance (AMR), hospital surveillance methods and tools used to control HCAI infections
Review of the U.S. patent grants for innovations in infectious diseases control and viral infections
Profile descriptions of the leading industry players including 3M, Merck, Novartis’, Pfizer, Roche, and Sanofi

Chapter 1 Introduction

Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
Custom Research
Related Reports

Chapter 2 Summary and Highlights

Chapter 3 Overview

Healthcare-Acquired Infections
Types of Infections
Central-Line-Associated Bloodstream Infections
Surgical Site Infections
Catheter-Associated Urinary Tract Infections
Ventilator-Associated Pneumonia
Diseases and Infectious Agents in Healthcare Settings
Acinetobacter
Burkholderia Cepacia
Clostridium Difficile
Clostridium Sordellii
Enterobacteriaceae (Carbapenem-Resistant)
Gram-Negative Bacteria
Hepatitis
HIV/AIDS
Influenza
Klebsiella
Methicillin-Resistant Staphylococcus aureus
Mycobacterium Abscessus
Norovirus
Pseudomonas Aeruginosa
Staphylococcus Aureus
Vancomycin-Resistant Enterococci
Incidence and Prevalence
Risk Factors
Prevention Strategies
Basic Infection Prevention and Control
Antibiotics and Multidrug-Resistant Organisms
Device-Associated Infection Control
Procedure-Associated Guidelines
Setting Specific Guidelines
WHO Guidelines
Surveillance Systems

Chapter 4 Market Summary and Analysis

Global Market for Infection Control
Regional Analysis
Market Drivers
Antimicrobial Resistance
Increasing Population and Demographic Changes
Emerging Markets
New Technologies
Vaccine Coverage
Increase in Focus on HCAIs
Market Deterrents
Cost-Effectiveness of Newer Methods
Unmet Needs
Effective Treatment for "Superbugs"

Chapter 5 Pharmaceuticals

HCAI Pharmaceutical Market
Antibiotics
Mechanism of Action
Antibiotic Resistance
Mechanisms of Antibiotic Resistance
Reasons for Antibiotic Resistance
Antimicrobial Resistance (Antibiotics): Incidence
Antibiotic Resistance: Hospitals and Healthcare Settings
Davos Declaration for Combating Antimicrobial Resistance
Antibiotics for Bacterial HCAIs
Select Marketed Antibiotics
Global Market for Antibiotics
Antifungal Drugs
Antifungals for HCAI
Select Marketed Antifungals
Global Market for Antifungals
Antivirals and Vaccines
Hepatitis B and Hepatitis C
Influenza

Chapter 6 Environmental Treatment

HCAI: Environmental Treatment Market
Disinfectants
Types
Key Marketed Hospital-Use Disinfectants
Patient Skin Preparation
Key Marketed Patient Skin Preparation Antiseptics
Patient Skin Preparation Market
Environment Sterilization
Air Treatment
Room Filtration Systems
Room Pressurization
UV Light Disinfection
Water Treatment
Equipment/Facility Sterilization
Heat Sterilization
Chemical Sterilization
Radiation-Based Sterilization
Environment Sterilization Market

Chapter 7 Medical Devices

HCAI Medical Device Market
Antimicrobial Coatings
Catheters
Patient Ventilation Devices
Types
Treatments and Devices
IV Filters
IV Filter Market

Chapter 8 Industry Structure

Industry Structure for Healthcare Infection Prevention
Suppliers
Customers
Consumers

Chapter 9 Research and Opportunities

New Technologies
Hand Hygiene
Patient Tracing
Self-Disinfecting Surfaces
Automated Decontamination Technologies
Smart Systems and Predictive Analytics
Other Technologies
Antibiotics Pipeline
Viral Infection Pipeline: Hepatitis B Treatments
Pipeline of Viral Infection Influenza Treatments
Fungal Infection Treatment Pipeline

Chapter 10 Patent/Patent Application Analysis

Pharmaceuticals
Antibiotics
Hepatitis B Treatments
Hepatitis C Treatments
Influenza Treatments
Antifungal Treatments
Environment Sterilization
Disinfectants
Patient Skin Preparation Treatments
Air Treatment Technologies
Water Treatment Technologies
Medical Devices
Catheters and Endotracheal Tubes
IV Filters (In-Line)

Chapter 11 Company Profiles

Pharmaceutical Companies
Gilead Sciences
Merck
Novartis
Pfizer
Roche
Sanofi Pasteur
Seqirus
Companies In Sterilization/Disinfection Industry
3M Healthcare
Advanced Sterilization Products
Becton, Dickinson And Company
Belimed
The Clorox Company
Sterigenics
Xenex Disinfection Services
Medical Device Companies
Bactiguard
Teleflex

Chapter 12 Appendix

List of Tables

Summary Table B: Global Market for HCAI Control, by Region, Through 2026
Summary Table A: Global Market for HCAI Control, by Segment, Through 2026
Table 1: Pooled Cumulative Incidence of HCAI and Device-Associated Infections in Adults, 1995-2010
Table 2: HCAIs, LTACHs and IRFs in the U.S., 2019
Table 3: SSI Rates for Select Procedures, U.S., 2019
Table 4: Sterilization and Disinfection Methods, CDC Guidelines, Updated February 2017
Table 5: Air-Handling Systems in Healthcare, CDC Recommendations, Updated February 2017
Table 6: Controlling Spread of Waterborne Infections, CDC Recommendations, Updated February 2017
Table 7: Routine Prevention of Waterborne Microbial Contamination within the Distribution System, CDC Recommendations, Updated February 2017
Table 8: Proportion of Resistant Strains, by WHO Region
Table 9: WHO Priority List, Pathogens for R&D of New Antibiotics
Table 10: Administrative Measures, MDROs, CDC Recommendations, Updated 2006
Table 11: Education and Training, MDROs, CDC Recommendations, Updated 2006
Table 12: Judicious Use of Antimicrobial Agents, MDROs, CDC Recommendations, Updated 2006
Table 13: Surveillance, MDROs, CDC Recommendations, Updated 2006
Table 14: Appropriate Urinary Catheter Use, CDC Recommendations, Updated 2009
Table 15: Urinary Catheter Maintenance, CDC Recommendations, Updated 2009
Table 16: Summary of Recommendations, CRBSI, CDC, Updated 2011
Table 17: SSI, CDC Recommendations, Updated 2017
Table 18: Dialysis, CDC Recommendations, Updated 2016
Table 19: Core Components of IPC Programs at the National and Acute Healthcare Facility Level, HCAIs, WHO Recommendations, Updated 2016
Table 20: Surveillance Elements and Methodology, CDC, Updated 2006
Table 21: Global Market for HCAI Control, by Segment, Through 2026
Table 22: Global Market for HCAI Control, by Region, Through 2026
Table 23: Global Market for HCAI Pharmaceuticals, by Category, Through 2026
Table 24: Proportion of Resistant Strains, by WHO Region
Table 25: WHO Priority List, Pathogens for R&D of New Antibiotics
Table 26: Select Branded Antibiotics, by Manufacturer
Table 27: Global Market for HCAI Antibiotics, by Class (ATC Code), Through 2026
Table 28: Global Market for HCAI Antibiotics, by Region, Through 2026
Table 29: Select Branded Antifungals, by Manufacturer
Table 30: Global Market for HCAI Antifungals, by Class, Through 2026
Table 31: Global Market for HCAI Antifungals, by Region, Through 2026
Table 32: Key Marketed Hepatitis B Drugs
Table 33: Global Market for Hepatitis B Therapeutics for HCAIs, by Region, Through 2026
Table 34: Global Market for Hepatitis B Vaccines for HCAIs, by Region, Through 2026
Table 35: Key Marketed Hepatitis C Drugs
Table 36: Global Market for Hepatitis C Therapeutics for HCAIs, by Region, Through 2026
Table 37: Key Marketed Influenza Vaccines
Table 38: Key Marketed Antivirals for Influenza
Table 39: Global Market for Influenza Vaccines for HCAIs, by Region, Through 2026
Table 40: Global Market for HCAI Environment Treatment, by Category, Through 2026
Table 41: Select Branded Disinfectants, by Manufacturer
Table 42: Global Market for Disinfectant in Hospitals, by Region, Through 2026
Table 43: Select Branded Skin Antiseptics (Preoperative Care), by Manufacturer
Table 44: Global Market for Presurgical Skin Preparation, by Region, Through 2026
Table 45: Global Market for Air-Filtration in Hospitals, by Region, Through 2026
Table 46: Global Market for High-Temperature Sterilization, by Region, Through 2026
Table 47: Global Market for Low-Temperature Sterilization, by Category, Through 2026
Table 48: Global Market for Low-Temperature Sterilization, by Region, Through 2026
Table 49: Global Market for Radiation-Based Sterilization, by Category, Through 2026
Table 50: Global Market for Radiation-Based Sterilization, by Region, Through 2026
Table 51: Global Market for HCAI Medical Devices, by Category, Through 2026
Table 52: Global Market for Coated Catheters, by Category, Through 2026
Table 53: Global Market for Coated Catheters, by Region, Through 2026
Table 54: Global Market for Coated Endotracheal Tube, by Region, Through 2026
Table 55: Global Market for IV Filters by Region, Through 2026
Table 56: Global Antibiotics Development Pipeline
Table 57: Hepatitis B and Hepatitis C Clinical Pipeline
Table 58: Influenza A and Influenza B Clinical Pipeline
Table 59: Antifungal Clinical Pipeline
Table 60: Number of Patents/Patent Applications on Antibiotics, 2014-2019
Table 61: Number of Patents/Patent Applications on Hepatitis B Treatments, 2014-2019
Table 62: Number of Patents/Patent Applications on Hepatitis C Treatments, 2014-2019
Table 63: Number of Patents/Patent Applications on Influenza Treatments, 2014-2019
Table 64: Number of Patents/Patent Applications on Antifungal Treatments, 2014-2019
Table 65: Number of Patents/Patent Applications on Disinfectants, 2014-2019
Table 66: Number of Patents/Patent Applications on Patient Skin Preparation Treatments, 2014-2019
Table 67: Number of Patents/Patent Applications on Air Treatment, 2014-2019
Table 68: Number of Patents/Patent Applications on Water Treatment, 2014-2019
Table 69: Number of Patents/Patent Applications on Catheters and ETTs, 2014-2019
Table 70: Acronyms Used in This Report
Table 71: Glossary of Terms Used in Global Markets for Infectious Diseases
Table 72: Report Sources

List of Figures

Summary Figure A: Global Market for HCAI Control, by Segment, 2020-2026
Summary Figure B: Global Market for HCAI Control, by Region, 2020-2026
Figure 1: Antibiotic Use* by Class, Select Classes, 2010 and 2015
Figure 2: Global Market for HCAI Control, by Segment, 2020-2026
Figure 3: Global Market for HCAI Control, by Region, 2020-2026
Figure 4: Global Market for HCAI Pharmaceuticals, by Category, 2020-2026
Figure 5: Antibiotic Use* by Class, Select Classes, 2000 and 2010
Figure 6: Global Market for HCAI Antibiotics, by Class (ATC Code), 2020-2026
Figure 7: Global Market for HCAI Antibiotics, by Region, 2020-2026
Figure 8: Global Market for HCAI Antifungals, by Class, 2020-2026
Figure 9: Global Market for HCAI Antifungals, by Region, 2020-2026
Figure 10: Global Market for Hepatitis B Therapeutics for HCAIs by Region, 2020-2026
Figure 11: Global Market for Hepatitis B Vaccines for HCAIs, by Region, 2020-2026
Figure 12: Global Market for Hepatitis C Therapeutics for HCAIs, by Region, 2020-2026
Figure 13: Global Market for Influenza Vaccines for HCAIs, by Region, 2020-2026
Figure 14: Global Market for HCAI Environment Treatment, by Category, 2020-2026
Figure 15: Global Market for Disinfectant Use in Hospitals, by Region, 2020-2026
Figure 16: Global Market for Presurgical Skin Preparation, by Region, 2020-2026
Figure 17: Global Market for Air-Filtration inHospitals, by Region, 2020-2026
Figure 18: Global Market for Air-Filtration inHospitals, by Region, 2020-2026
Figure 19: Global Market for Low-Temperature Sterilization, by Category, 2020-2026
Figure 20: Global Market for Low-Temperature Sterilization, by Region, 2020-2026
Figure 21: Global Market for Radiation-Based Sterilization, by Category, 2020-2026
Figure 22: Global Market for Radiation-Based Sterilization, by Region, 2020-2026
Figure 23: Global Market for HCAI Medical Devices, by Category, 2020-2026
Figure 24: Global Market for Coated Catheters, by Category, 2020-2026
Figure 25: Global Market for Coated Catheters, by Region, 2020-2026
Figure 26: Global Market for Coated Endotracheal Tube, by Region, 2020-2026
Figure 27: Global Market for IV Filters, by Region, 2020-2026
Figure 28: HCAI-Prevention Industry Structure

Companies Mentioned

3M Healthcare
Advanced Sterilization Products
Bactiguard
Becton, Dickinson And Company
Belimed
Gilead Sciences
Merck
Novartis
Pfizer
Roche
Sanofi Pasteur
Seqirus
Sterigenics
Teleflex
The Clorox Company
Xenex Disinfection Services

Table Information

Report Attribute	Details
No. of Pages	213
Published	June 2021
Forecast Period	2021 - 2026
Estimated Market Value ( USD ) in 2021	$ 24 Billion
Forecasted Market Value ( USD ) by 2026	$ 36.2 Billion
Compound Annual Growth Rate	8.6%
Regions Covered	Global
No. of Companies Mentioned	16

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€2644EUR$2,750USD£2,268GBP €5288EUR$5,500USD£4,537GBP
1 - 5 USER LICENSE PDF	The product is a PDF.	This is a 1-5 user license, allowing up to five users have access to the product.	€3173EUR$3,300USD£2,722GBP €6346EUR$6,600USD£5,444GBP
SITE LICENSE PDF	The product is a PDF.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€3808EUR$3,960USD£3,267GBP €7615EUR$7,920USD£6,533GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€4569EUR$4,752USD£3,920GBP €9139EUR$9,504USD£7,840GBP

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

Medical Device Cleaning - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

North America Hospital Supplies - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

Hospital Acquired Infection Treatment Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Class, Infection Type, Distribution Channel, and Geography

Prosthetic Joint Infection Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Herbal Drugs for the Management of Infectious Diseases. Edition No. 1